DrugPatentWatch Database Preview
Tenecteplase - Biologic Drug Details
» See Plans and Pricing
Summary for tenecteplase
| Tradenames: | 1 |
| Patents: | 65 |
| Applicants: | 1 |
| BLAs: | 1 |
| Suppliers: see list | 1 |
| Recent Clinical Trials: | See clinical trials for tenecteplase |
Recent Clinical Trials for tenecteplase
Identify potential brand extensions & biosimilar entrants
| Sponsor | Phase |
|---|---|
| General Hospital of Shenyang Military Region | N/A |
| Hui-Sheng Chen | N/A |
| The First Affiliated Hospital of Zhengzhou University | Phase 2 |
Patent Text Search: US Patents for tenecteplase
| Applicant | Tradename | Biologic Ingredient | Dosage Form | BLA | Number | Approval Date | Patent No. | Assignee | Estimated Patent Expiration | Status | Orphan | Source |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Genentech | TNKASE | tenecteplase | VIAL | 103909 | 001 | 2000-06-02 | Start Trial | Bristol-Myers Squibb Co. (Princeton, NJ) | 2021-12-10 | RX | search | |
| Genentech | TNKASE | tenecteplase | VIAL | 103909 | 001 | 2000-06-02 | Start Trial | Genentech, Inc. (South San Francisco, CA) Boehringer Ingelheim Pharmaceuticals, Inc. (Ridgefield, CT) Aventis Pharma, S.A. (Antony, FR) Boehringer Ingelheim Pharma KG (Ingelheim/Rhein, DE) | 2022-02-22 | RX | search | |
| Genentech | TNKASE | tenecteplase | VIAL | 103909 | 001 | 2000-06-02 | Start Trial | Schering Corporation (Kenilworth, NJ) | 2023-12-19 | RX | search | |
| Genentech | TNKASE | tenecteplase | VIAL | 103909 | 001 | 2000-06-02 | Start Trial | 2023-03-07 | RX | search | ||
| Genentech | TNKASE | tenecteplase | VIAL | 103909 | 001 | 2000-06-02 | Start Trial | Evonik Degussa GmbH (Essen, DE) | 2021-10-30 | RX | search | |
| Genentech | TNKASE | tenecteplase | VIAL | 103909 | 001 | 2000-06-02 | Start Trial | Genentech, Inc. (South San Francisco, CA) | 2021-11-26 | RX | search | |
| Genentech | TNKASE | tenecteplase | VIAL | 103909 | 001 | 2000-06-02 | Start Trial | Wacker Chemie AG (Munich, DE) | 2026-10-25 | RX | search | |
| >Applicant | >Tradename | >Biologic Ingredient | >Dosage Form | >BLA | >Number | >Approval Date | >Patent No. | >Assignee | >Estimated Patent Expiration | >Status | >Orphan | >Source |
International Patents for tenecteplase
| Country | Patent Number | Estimated Expiration |
|---|---|---|
| Poland | 3100728 | Start Trial |
| Japan | 6357111 | Start Trial |
| Mexico | 2013007381 | Start Trial |
| World Intellectual Property Organization (WIPO) | 2004080335 | Start Trial |
| China | 103391785 | Start Trial |
| Japan | 2019504070 | Start Trial |
| Peru | 20090241 | Start Trial |
| >Country | >Patent Number | >Estimated Expiration |
